Joint pain can make everyday activities, from walking and exercising to simply getting through the day, more difficult. For some patients, platelet-rich plasma therapy, commonly known as PRP, may be one option to help manage pain and support the body’s natural healing response.

Florida Orthopaedic Institute’s Grant G. Garlick, MD, recently appeared on Tampa Bay’s Morning Blend to discuss PRP therapy, how the treatment works and what patients should know when considering it as part of their orthopaedic care.

What Is PRP Therapy?

PRP is a minimally invasive treatment that uses a concentrated portion of a patient’s own blood.

A small blood sample is collected and processed in a specialized centrifuge to concentrate platelets. The platelet-rich plasma is then injected into the targeted area, where it may help support tissue repair and the body’s natural healing processes.

At Florida Orthopaedic Institute, PRP may be considered for certain joint, tendon and musculoskeletal conditions after a comprehensive evaluation and diagnosis.

Is PRP Right for Everyone?

PRP is not appropriate for every patient or every orthopaedic condition. The first step is understanding the source of the pain and determining which treatment options are most appropriate for the individual patient.

Dr. Garlick specializes in knee conditions, joint replacement and sports medicine and incorporates treatments such as PRP into individualized care plans when clinically appropriate.

For patients experiencing ongoing joint or tendon pain, an orthopaedic evaluation can help determine whether PRP or another treatment option may be appropriate based on the diagnosis, symptoms, activity goals and overall health.

Watch Dr. Grant Garlick’s conversation on Tampa Bay’s Morning Blend to learn more about PRP therapy for joint pain and how it may be used as part of orthopaedic care.

Learn More About PRP at Florida Orthopaedic Institute

If joint or tendon pain is keeping you from the activities you enjoy, learn more about platelet-rich plasma therapy and whether it may be appropriate for you.

October 6, 2026